Status:
COMPLETED
Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Substance Use Disorders
Depression
Eligibility:
All Genders
18-26 years
Phase:
NA
Brief Summary
The overall aim of this pilot study is to conduct a preliminary trial to evaluate the acceptability and feasibility of adding a transdiagnostic, emotion-focused group intervention (the Unified Protoco...
Detailed Description
Young adults with substance use disorder (SUD) commonly experience co-occurring emotional distress in the form of affective/emotional disorders (i.e. anxiety, depressive, and related disorders) and se...
Eligibility Criteria
Inclusion
- Only patients seeking services or currently engaged in care at the MGH Addiction Recovery Management Service are eligible for this study.
- Young adults ages 18 to 26, inclusive
- English language proficiency
- Ability to provide written, informed consent
- Ability to attend in-person, outpatient sessions
- Has provided consent to receive or is currently undergoing treatment at the MGH Addiction Recovery Management Service
- Documented DSM-5 SUD diagnosis (limited to alcohol use disorder; cannabis use disorder; phencyclidine or other hallucinogen use disorder; inhalant use disorder, opioid use disorder; sedative, hypnotic, or anxiolytic use disorder; stimulant use disorder; other (or unknown) SUD)
- Current elevated emotional distress, as evidenced by any one of the following:
- Score at least in the moderate range on self-report anxiety questionnaire
- Score at least in the moderate range on self-report depression questionnaire
- Report of suicidal thoughts in the past week
- Report of engagement in non-suicidal self-injury in the past week
- Not expected to require inpatient level of care within the next two weeks (as judged clinically)
Exclusion
- Documented psychotic disorder (or current, clinically significant psychotic symptoms) that render the patient inappropriate for outpatient level of care or participation in group therapy (as judged clinically by study staff)
- Current imminent suicide or homicide risk (as judged clinically by study staff)
- Unwilling or unable to provide consent for study staff to access subject's medical records and coordinate care and exchange data with clinical staff at the Addiction Recovery Management Service
- Unwilling or unable to identify an emergency contact
Key Trial Info
Start Date :
November 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2019
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03315208
Start Date
November 22 2017
End Date
September 20 2019
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Addiction Recovery Management Service
Boston, Massachusetts, United States, 02114